Skip to content

Increasing Transparency in Generic Drug Applications Act

Health

119-s1302 — Increasing Transparency in Generic Drug Applications Act. Sponsored by Sen. Hassan, Margaret Wood [D-NH]. Introduced 2025-04-03. Senate bill. 119th Congress. Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

119-s1302 119th Congress Senate
XML Congress.gov
Sponsor
Sen. Hassan, Margaret Wood [D-NH] (D), NH
Introduced
2025-04-03
Committees
Health, Education, Labor, and Pensions Committee
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

No roll-call vote data available for this bill.

Similar Bills

  • 117-s4338 — Increasing Transparency in Generic Drug Applications Act of 2022 67% match 117th Congress
  • 118-s1114 — Increasing Transparency in Generic Drug Applications Act 64% match 118th Congress
  • 119-hr1843 — To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. 47% match
  • 118-s4490 — WAE Act 47% match 118th Congress
  • 118-s4494 — WIL Act 47% match 118th Congress
Investigate this bill → Beneficiary scoring, topic classification, and fiscal analysis